A year after refusing to take up a controversial fee decision in the Roundup multidistrict litigation, the U.S. Court of Appeals for the Ninth Circuit upheld a federal judge's authority to impose common benefit assessments in a separate case involving C.R. Bard Inc.'s medical devices.